The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years

Modeling Health Care Expenditures and Use

(2018) Partha Deb et al.   Annual Review of Public Health

Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study

(2018) Levente Parragi et al.   Journal of Crohns & Colitis

Chronic comorbidities associated with inflammatory bowel disease

(2017) Caroline Bähler et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

(2017) Siew C Ng et al.   LANCET

Crohn's disease

(2017) Joana Torres et al.   LANCET

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease

(2017) Nadia Pillai et al.   PLoS One

Indirect costs of inflammatory bowel diseases: Crohn’s disease and ulcerative colitis. A systematic review

(2016) Paweł Kawalec   Archives of Medical Science

Biosimilars in IBD: from theory to practice

(2016) Silvio Danese et al.   Nature Reviews Gastroenterology & Hepatology

Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up

(2016) Mirthe E. van der Valk et al.   PLoS One

Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort

(2015) Johan Burisch et al.   INFLAMMATORY BOWEL DISEASES

Extraintestinal Manifestations of Inflammatory Bowel Disease

(2015) Stephan R. Vavricka et al.   INFLAMMATORY BOWEL DISEASES

Difference-in-difference estimation by FE and OLS when there is panel non-response

(2015) Michael Lechner et al.   JOURNAL OF APPLIED STATISTICS

Health care cost in Switzerland: Quantity- or price-driven?

(2014) Reto Schleiniger   HEALTH POLICY

The Epidemiology of Colectomy in Ulcerative Colitis: Results From a Population-Based Cohort

(2012) Laura E Targownik et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

(2012) Mirthe Emilie van der Valk et al.   GUT

Systematic review: the costs of ulcerative colitis in Western countries

(2010) R. D. COHEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort

(2010) Stephan R Vavricka et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Review of statistical methods for analysing healthcare resources and costs

(2010) Borislava Mihaylova et al.   HEALTH ECONOMICS

Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study

(2008) Brian G. Feagan et al.   GASTROENTEROLOGY

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY

Cohort Profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)

(2008) V. Pittet et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study

(2007) Pascal Juillerat et al.   Journal of Crohns & Colitis